11:57 AM EST, 11/14/2025 (MT Newswires) -- Mineralys Therapeutics ( MLYS ) shares were down more than 10% in recent Friday trading following a series of stock sales by a number of company executives.

Filings with the US Securities and Exchange Commission Thursday showed that Chief Executive Officer Jon Congleton and Chief Financial Officer Adam Levy, along with directors Daphne Karydas and Alexander Gold, recently sold Mineralys shares in a number of transactions.

Congleton sold 200,000 shares, bringing his holdings down to 631,305 while Levy sold nearly 120,000 shares and now holds 19,396 shares following the transactions, according to the filings.

Price: 39.79, Change: -4.50, Percent Change: -10.16